drugset / Trial / NCT01339143

Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes

NCT01339143

Phase 4 Unknown 80 enrolled Korea University Anam Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect of vildagliptin vs. pioglitazone to oxidative stress on daily blood glucose fluctuations, in patients with type 2 diabetes that was inadequately controlled by metformin.

Timeline

Start
2010-04
Primary completion
2012-12
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pioglitazone Small molecule 15 mg Oral
Subject Vildagliptin Other / unclassified 50 mg Oral